BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 114586)

  • 1. On the interaction of rabbit C1q with sheep and rabbit immune complexes.
    Liberti PA; Baillie RD; Milligan KF; Bausch DM
    J Immunol; 1979 Nov; 123(5):2212-9. PubMed ID: 114586
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of C1-mediated immune hemolysis by monomeric and dimeric peptides from the second constant domain of human immunoglobulin G.
    Lukas TJ; Muñoz H; Erickson BW
    J Immunol; 1981 Dec; 127(6):2555-60. PubMed ID: 7299136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between the binding ability and the rate of activation of the complement component C1.
    Folkerd EJ; Gardner B; Hughes-Jones NC
    Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of C-1 on the size of soluble immune aggregates and on their processing by macrophages.
    Kijlstra A; van Es LA; Daha MR
    J Immunol; 1979 Aug; 123(2):640-5. PubMed ID: 458153
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of C1, C1-inactivator and C4 in modulating immune precipitation.
    Schifferli JA; Steiger G; Schapira M
    Clin Exp Immunol; 1985 Jun; 60(3):605-12. PubMed ID: 4017288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sheep serum complement sensitisation of sheep erythrocyte-rabbit antibody complexes for haemolysis by guinea-pig complement plus EDTA or Mg2+-EGTA.
    Jonas W; Stankiewicz M
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):451-60. PubMed ID: 3099725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding and activation of hemolytic complement by IgG antibodies: cooperativity between antibodies of different hapten specificity.
    Borsos T; Circolo A
    J Immunol; 1985 Jan; 134(1):492-4. PubMed ID: 3964818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the binding of C1q to immune complexes by polyethylene glycol.
    Wines BD; Easterbrook-Smith SB
    Mol Immunol; 1988 Mar; 25(3):263-6. PubMed ID: 3259672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
    Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E; Sorvillo J; Gigli I
    J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
    Doekes G; van Es LA; Daha MR
    Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection.
    Oldstone MB; Buchmeier MJ; Doyle MV; Tishon A
    J Immunol; 1980 Feb; 124(2):831-8. PubMed ID: 6444319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding site for C1q on IgG.
    Duncan AR; Winter G
    Nature; 1988 Apr; 332(6166):738-40. PubMed ID: 3258649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interactions between collagen and C1q: their significance for rheumatology].
    Menzel EJ
    Z Rheumatol; 1980; 39(7-8):251-83. PubMed ID: 7006253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational changes in C1q after binding to immune complexes: detection of neoantigens with monoclonal antibodies.
    Golan MD; Burger R; Loos M
    J Immunol; 1982 Aug; 129(2):445-7. PubMed ID: 6177765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complement fixation ability of precipitating and co-precipitating antibodies of various animal species].
    Perdigón G; Gentile T; Margni A
    Rev Argent Microbiol; 1979; 11(1):1-6. PubMed ID: 538236
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.